{"id":1038087,"date":"2020-12-28T15:54:55","date_gmt":"2020-12-28T20:54:55","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/is-aim-immunotech-inc-aim-a-winner-in-the-biotechnology-industry-investorsobserver\/"},"modified":"2024-08-17T16:13:51","modified_gmt":"2024-08-17T20:13:51","slug":"is-aim-immunotech-inc-aim-a-winner-in-the-biotechnology-industry-investorsobserver","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-aim-immunotech-inc-aim-a-winner-in-the-biotechnology-industry-investorsobserver.php","title":{"rendered":"Is AIM ImmunoTech Inc (AIM) a Winner in the Biotechnology Industry? &#8211; InvestorsObserver"},"content":{"rendered":"<p><p>A rating of 12 puts AIM ImmunoTech Inc (AIM) near the bottom of the Biotechnology industry according to InvestorsObserver. AIM ImmunoTech Inc's score of 12 means it scores higher than 12% of stocks in the industry. AIM ImmunoTech Inc also received an overall rating of 20, putting it above 20% of all stocks. Biotechnology is ranked 32 out of the 148 industries.<\/p>\n<p>Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 20 would rank higher than 20 percent of all stocks.<\/p>\n<p>Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.<\/p>\n<p>AIM ImmunoTech Inc (AIM) stock is lower by -2.91% while the S&P 500 has gained 0.39% as of 10:43 AM on Wednesday, Dec 23. AIM is down -$0.06 from the previous closing price of $2.06 on volume of 958,792 shares. Over the past year the S&P 500 has gained 14.83% while AIM has gained 308.16%. AIM lost -$0.44 per share the over the last 12 months. <\/p>\n<p>Click Here to get the full Stock Score Report on AIM ImmunoTech Inc (AIM) Stock.<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.investorsobserver.com\/news\/stock-update\/is-aim-immunotech-inc-aim-a-winner-in-the-biotechnology-industry-2\" title=\"Is AIM ImmunoTech Inc (AIM) a Winner in the Biotechnology Industry? - InvestorsObserver\" rel=\"noopener noreferrer\">Is AIM ImmunoTech Inc (AIM) a Winner in the Biotechnology Industry? - InvestorsObserver<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A rating of 12 puts AIM ImmunoTech Inc (AIM) near the bottom of the Biotechnology industry according to InvestorsObserver. AIM ImmunoTech Inc's score of 12 means it scores higher than 12% of stocks in the industry <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-aim-immunotech-inc-aim-a-winner-in-the-biotechnology-industry-investorsobserver.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1038087","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038087"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1038087"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038087\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1038087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1038087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1038087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}